Skip to main content
SpringerLink
Log in

Evaluation of sensitivity to 5-FU on the basis of thymidylate synthase (TS)/dihydropyrimidine dehydrogenase(DPD) activity and chromosomal analysis in micro tissue specimens of breast cancer

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

Preoperative assessment of the anticancer drug sensitivity of tumors plays an important role in the selection of therapy. If evaluation of the 5-FU sensitivity of microtissue specimens obtained by techniques such as core needle biopsy could be performed, the addition of fluorouracil to adriamycin and cyclophosphamide may further enhance response rates. In order to evaluate a simple sensitivity test for the anti-tumor agent 5-fluorouracil (5-FU), we examined whether an assay of a small sample could measure mRNA to predict the activities of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD). In addition, gene abnormalities on chromosomes 1 and 18 corresponding to DPD, TS and the relationships between the gene abnormalities and the amount of mRNA and activity were examined.

Method

TS and DPD activity were measured using the fluorodeoxyuridine monophosphate ligand binding assay and radio enzymatic assay, respectively, while mRNA levels were assayed by real-time polymerase chain reaction. Chromosome 1 and 18 aberrations were investigated by fluorescencein situ hybridization (FISH) with centromere probes.

Results

TS mRNA and TS activity showed a positive correlation (r = 0.518,p = 0.0017). TS activity and TS mRNA were significantly higher in the nuclear grade 3 group than in the other groups (p = 0.04,p = 0.0072, respectively). TS activity and mRNA in tumor tissue tended to decrease in the progesterone receptor positive groups (p = 0.059,p = 0.066, respectively). There was no correlation between DPD mRNA and DPD activity in tumor tissue (r = 0.139,p = 0.4423). DPD mRNA was measured as 282.88 ± 170.68 copies/cell in tumor tissue and 635.88 ± 310.04 copies/cell in normal tissue, and was thus significantly higher in normal tissue (p < 0.001).

Conclusions

TS mRNA showed a positive correlation with TS activity, suggesting that this method of using small amounts of tissue can replace anti-cancer drug sensitivity tests.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

TS:

Thymidylate synthase

DPD:

Dihydropyrimidine Dehydrogenase

5-FU:

5-fluorouracil

FUDP:

Fluorouridine diphosphate

FdUMP:

Fluorodeoxyuridine monophsphate

FISH:

Fluorescencein situ hybridization

PCR:

Polymerase chain reaction

ER:

Estrogen receptor

PgR:

Progesterone receptorM

References

  1. van Laar JA, Rustum YM, Ackland SP, van Groeningen CJ, Peters GJ: Comparison of 5-fluoro-2’ -deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer.Eur J Cancer 34:296–306, 1998.

    Article  PubMed  Google Scholar 

  2. Etienne MC, Cheradame S, Fischel JL, Formento P, Dassonville O, Renee N, Schneider M, Thyss A, Demard F, Milano G: Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydorogenase activity.J Clin Oncol 13:1663–1670, 1995.

    PubMed  CAS  Google Scholar 

  3. Yokota H, Fernandez-Salguero P, Furuya H, Lin K, McBride OW, Podschun B, Schnackerz KD, Gonzalez FJ: cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxity and congenital thymine uraciluria.J Biol Chem 269:23192–23196, 1994.

    PubMed  CAS  Google Scholar 

  4. Hori T, Takahashi E, Ayusawa D, Takeishi K, Kaneda S, Seno T: Regional assignment of the human thymidylate synthase (TS) gene to chromosome band 18p11.32 by nonisotopic in situ hybridization.Hum Genet 85:576–580, 1990.

    Article  PubMed  CAS  Google Scholar 

  5. Japan Breast Cancer Society: General rules for clinical and pathological record of breast cancer. 14th ed, Kanahara Shuppan, Tokyo, 2000.

  6. Tsuda H, Takarabe T, Akashi-Tanaka S, Fukutomi T, Nanasawa T, Watanabe T: Evaluation of histological criteria for identifying node-negative breast cancer with high risk of early recurrence in the NSAS-BC protocol study.Breast Cancer 7:201–209, 2000.

    Article  PubMed  CAS  Google Scholar 

  7. Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH: In vivo kinetics of thymidylate synthetase inhibition in 5-fuluorouracil -sensitive and resistat murine colon adenocarcinomas.Cancer Res 42:450–456, 1982.

    PubMed  CAS  Google Scholar 

  8. Takechi T, Uchida J, Fujioka A, Fukushima M: Enhancing 5-fluorouracil cytotoxicity by inhibiting dihydropyrimidine dehydrogenase activity with uracil in human tumor cell.Int J Oncol 11:1041–1044, 1997.

    CAS  Google Scholar 

  9. Gibson UEM, Heid CA, Williams PM: A novel method for real time quantitative RT-PCR.Genome Res 10:995–1001, 1996.

    Article  Google Scholar 

  10. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative PCR.Genome Res 10:986–994, 1996.

    Article  Google Scholar 

  11. Puissant C, Houdebine LM: An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Biotechniques 8:148–149, 1990.

    Article  PubMed  CAS  Google Scholar 

  12. Takami S, Kawasome C, Moritoshi K, Koyama H, Noguchi S: Chromosomal instability detected by fluorescence in situ hybridization in Japanese breast cancer.Clinica Chmica Acta 308:127–131, 2001.

    Article  CAS  Google Scholar 

  13. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers.Nature 386:2064–2069, 1997.

    Article  Google Scholar 

  14. Ichikawa D, Hashimoto N, Hoshima M, Yamaguchi T, Sawai K, Nakamura Y, Takahashi T, Abe T, Inazawa J: Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer.Cancer 77:2064–2069, 1996.

    Article  PubMed  CAS  Google Scholar 

  15. Kasumi F, Yoshimoto M, Uchino J, Abe R, Nomura Y, Sugimachi K, Nakazato H, Abe O: Meta-analysis of five studies on tegafur plus uracil (UFT) as post-operative adjuvant chemotherapy for breast cancer.Oncology 64:146–153, 2003.

    Article  PubMed  CAS  Google Scholar 

  16. Saikawa Y, Kubota T, Furukawa T, Suto A, Watanabe M, Kumai K, Ishibiki K, Kitajima M: Single-cell suspention assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer.Jpn J Cancer Res 85:762–765, 1994.

    PubMed  CAS  Google Scholar 

  17. Kubota T, Sasano N, Abe O, Nakao I, Kawamura E, Saito T, Endo M, Kimura K, Demura H, Sasano H, Nagura H, Ogawa N, Hoffman RM, and the Chemosensitivity Study Group for the Histoculuture DrugResponse Assay: Potential of the histoculture drugresponse assay to contribute to cancer patient survival.Clin Cancer Res 1:1537–1543, 1995.

    PubMed  CAS  Google Scholar 

  18. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.Cancer Res 55:1407–1412, 1995.

    PubMed  CAS  Google Scholar 

  19. Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Kitajima M, Takechi T, Okabe H, Fukushima M: Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.Clin Cancer Res 5:883–889, 1999.

    PubMed  CAS  Google Scholar 

  20. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA, Allegra CJ: The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.J Clin Oncology 12:2640–2647, 1994.

    CAS  Google Scholar 

  21. Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Takechi T, Okabe H, Fukushima M, Kitajima M: Thymidylate synthase and dihydropyrimidine dehyrogenase level in gastric cancer.Anticancer Res 19:5635–5640, 1999.

    PubMed  CAS  Google Scholar 

  22. Nishimura R, Nagao K, Miyayama H, Matsuda M, Baba K, Matsuoka Y, Yamashita H, Fukuda M, Higuchi A, Satoh A, Mizumoto T, Hamamoto R: Tymidylate synthase level as a therapeutic and prognostic predictor in breast cancer.Anticancer Res 19:5621–5626, 1999.

    PubMed  CAS  Google Scholar 

  23. Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV: Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.Clin Cancer Res 6:1322–1327, 2000.

    PubMed  CAS  Google Scholar 

  24. Mizutani Y, Wada H, Ogawa O, Yoshida O, Fukushima M, Nonomura N, Miki T: Prognostic significance of thymidylate synthase activity in bladder carcinoma.Cancer 92:510–518, 2001.

    Article  PubMed  CAS  Google Scholar 

  25. Terashima M, Irinoda T, Fujiwara H, Nakaya T, Takagane A, Abe K, Yonezawa H, Oyama K, Inaba T, Saito K, Takechi T, Fukushima M: Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.Anticancer Res 22:761–768, 2002.

    PubMed  CAS  Google Scholar 

  26. Fujiwara H, Terashima M, Irinoda T, Takagane A, Abe K, Kashiwaba M, Oyama K, Takahashi M, Maesawa C, Saito K, Takechi T, Fukushima M: Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.Jpn J Cancer Res 93:1342–1350, 2002.

    PubMed  CAS  Google Scholar 

  27. Ichikawa W, Uetake H, Shirota Y, Yamada H, Nishi N, Nihei Z, Sugihara K, Hirayama R: Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine -based chemotherapy for metastatic colorectal cancer.Clin Cancer Res 9:786–791, 2003.

    PubMed  CAS  Google Scholar 

  28. Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Takechi T, Okabe H, Fukushima M, Kitajima M: Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.Jpn J Cancer Res 91:105–112, 2000.

    PubMed  CAS  Google Scholar 

  29. Higashiyama M, Kodama K, Yokouchi H, Takami K, Fukushima M, Minamigawa K, Takano T, Kobayashi H: Thymidilate synthase and dihydropyrimidine dehydrogenase activities in non-small cell cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil.Lung Cancer 34:407–416, 2001.

    Article  PubMed  CAS  Google Scholar 

  30. Omura K, Kawakami K, Knehira E: Theoretical construction of chemotherapeutic tactics for advanced or recurrent gastrointestinal carcinoma.Gan To Kagaku Ryoho 28:63–68, 2001 (In Japanese with English abstract).

    PubMed  CAS  Google Scholar 

  31. Hakamada Y, Arima M, Misaka T, Yasuda D, Matsunaga T, Kusama M, Aoki T, Sekiguchi N, Koyanagi Y: Significance of thymidylate synthase and dihydropyrimidine dehydrogenase activity in breast cancer tissue.Gan To Kagaku Ryoho 27:1003–1010, 2000 (In Japanese with English abstract).

    PubMed  CAS  Google Scholar 

  32. Kosaka A, Mori K, Yomo A: Significance of tissue PyNPase, TS, and DPD activities in breast cancer.Gan To Kagaku Ryoho 29:1395–1401, 2002 (In Japanese with English abstract).

    PubMed  Google Scholar 

  33. Gomi T, Tamaki N, Momoi H, Isobe N, Kanaya S, Katayama T, Wada Y, Otoshi M: Investigation of thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancers. Proceeding of TS and DPD society, Tokyo, pp20–22, 2001 (In Japanese with English abstract). 34) Nagayama S, Morita M, Fukushima M: Population analysis of TS and DPD activity. Proceeding of TS and DPD society, Tokyo, pp2–3, 2001 (In Japanese with English abstract).

  34. Aitken SC, Lippman ME, Kasid A, Schoenberg DR: Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cell.Cancer Res 45:2608–2615, 1985.

    PubMed  CAS  Google Scholar 

  35. Fuqua SA, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O’Malley BW, McGuire WL: Variant human breast tumor estrogen receptor with constitutive transcriptional activity.Cancer Res 51:105–109, 1991.

    PubMed  CAS  Google Scholar 

  36. Uetake H, Ichikawa W, Takechi T, Fukushima M, Nihei Z, Sugihara K: Relationship between intratumoral dihydro-pyrimidine dehydrogenase activity and gene expression in human colorectal cancer.Clin Cancer Res 5:2836–2839, 1999.

    PubMed  CAS  Google Scholar 

  37. Johnston SJ, Ridge SA, Cassidy J, McLeod HL: Regulation of dihydropyrimidine dehydrogenase in colorectal cancer.Clin Cancer Res 5:2566–2570, 1999.

    PubMed  CAS  Google Scholar 

  38. Takabayashi A, Iwata S, Kawai Y, Kanai M, Taki Y, Takechi T, Fukushima M: Dihydropyrimidine dehydrogenase activity and mRNA expression in advanced gastric cancer analyzed in relation to effectiveness of preoperative 5-fluorauracil-based chemotherapy.Int J Oncol 17:889–895, 2000.

    PubMed  CAS  Google Scholar 

  39. Miyamoto S, Ochiai A, Boku N, Ohtsu A, Tahara M, Yoshida S, Okabe H, Takechi T, Fukushima M: Discrepancies between the gene expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehyrogenase in human gastrointestinal cancers and adjacent normal mucosa.Int J Oncol 18:705–713, 2001.

    PubMed  CAS  Google Scholar 

  40. Hamaji M, Miyazaki S, Nishida Y, Izukura M, Nishijima J, Oka Y, Seshimo I, Ohwari M: A preliminary study on dehydropyrimidine dihydrogenase activity in breast cancer.Gan To Kagaku Ryoho 27:1719–1724, 2000 (In Japanese with English abstract).

    PubMed  CAS  Google Scholar 

  41. Mcleod HL, Marsh S, McKay JA, Cassidy J: Thymidylate synthase pharmacogenetics in colorectal cancer.Proceeding of Am Soc Cli Cancer 129a, 2001.

  42. Leger I, Guillaud M, Krief B, Brugal G: Interactive computer-assisted analysis of chromosome 1 colocalization with nucleoli.Cytometry 16:313–323, 1994.

    Article  PubMed  CAS  Google Scholar 

  43. Farabegoli F, Santini D, Ceccarelli C, Taffurelli M, Marrano D, Baldini N: Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH.Cytometry 15:50–56, 2001.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, 160-0023, Shinjuku-ku, Tokyo, Japan

    Daisuke Ota, Mikihiro Kusama, Hiroshi Kaise, Shun Nakayama, Takeharu Misaka, Akihiko Tsuchida & Tatsuya Aoki

Authors
  1. Daisuke Ota
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mikihiro Kusama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroshi Kaise
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shun Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takeharu Misaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akihiko Tsuchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tatsuya Aoki
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Ota, D., Kusama, M., Kaise, H. et al. Evaluation of sensitivity to 5-FU on the basis of thymidylate synthase (TS)/dihydropyrimidine dehydrogenase(DPD) activity and chromosomal analysis in micro tissue specimens of breast cancer. Breast Cancer 11, 356–366 (2004). https://doi.org/10.1007/BF02968043

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02968043

Key words

Search

Navigation